臨床検査試験の世界市場:種類別(CBC、HGB/HCT、BMP、HbA1cテスト、電解質検査、肝パネル)、最終用途別(プライマリークリニック、セントラルラボ)、セグメント予測

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Market definition
1.3. Information procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources & third-party perspectives
1.3.4. Primary research
1.4. Information analysis
1.4.1. Data analysis models
1.5. Market formulation & data visualization
1.6. Data validation & publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Global Clinical Laboratory Tests Market Variables, Trends & Scope
3.1. Clinical Laboratory Tests Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Cost Structure Analysis
3.4. Reimbursement Framework
3.5. Market Dynamics
3.5.1. Market Driver Analysis
3.5.1.1. Rising geriatric population base
3.5.1.2. Growing prevalence of target diseases
3.5.1.3. Introduction of innovative solutions
3.5.1.4. Rising demand for early disease detection
3.5.2. Market Restraint Analysis
3.5.2.1. Presence of ambiguous regulatory framework
3.6. Clinical Laboratory Tests Market Analysis Tools
3.6.1. Industry Analysis – Porter’s
3.6.1.1. Supplier Power: Moderate due to large number of diagnostic test manufacturers
3.6.1.2. Buyer Power: Moderate due to presence of players entering into long-term contract
3.6.1.3. Substitution Threat: Low due to no/less external substitutes
3.6.1.4. Threat from new entrant: Moderate due to brand recognition of the existing players
3.6.1.5. Competitive rivalry: High due to increasing mergers & acquisitions by major players
3.7. PESTEL Analysis
3.7.1. Political Landscape
3.7.2. Environmental Landscape
3.7.3. Social Landscape
3.7.4. Technology Landscape
3.7.5. Legal Landscape
3.8. Major Deals & Strategic Alliances Analysis
3.8.1. Joint Ventures
3.8.2. Mergers & Acquisitions
3.8.3. Licensing & Partnership
3.8.4. Technology Collaborations
3.8.5. Strategic Divestments
Chapter 4. Clinical Laboratory Tests Market – Competitive Analysis
4.1. Recent developments & impact analysis, by key market participants
4.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
4.3. Public Companies
4.3.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
4.3.2. Company Market Share/Ranking, by region
4.3.3. Competitive Dashboard Analysis
4.3.4. Market Differentiators
4.3.5. Synergy Analysis: Major Deals & Strategic Alliances
4.4. Private Companies
4.4.1. List of key emerging companies
4.4.2. Regional network map
4.4.3. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
Chapter 5. Clinical Laboratory Tests Market: Type Estimates & Trend Analysis
5.1. Definitions & Scope
5.2. Type market share analysis, 2018 & 2026
5.3. Type Dashboard
5.4. Global Clinical Laboratory Tests Market, by Type, 2013 to 2026
5.5. Market Size & Forecasts and Trend Analyses, 2013 to 2026 for the following,
5.5.1. Complete blood count
5.5.1.1. Complete blood count market, 2014 – 2026 (USD Billion)
5.5.2. HGB/HCT testing
5.5.2.1. HGB/HCT testing market, 2014 – 2026 (USD Billion)
5.5.3. Basic metabolic panel testing
5.5.3.1. Basic metabolic panel market, 2014 – 2026 (USD Billion)
5.5.4. BUN creatinine testing
5.5.4.1. BUN creatinine testing market, 2014 – 2026 (USD Billion)
5.5.5. Electrolytes testing
5.5.5.1. Electrolytes testing market, 2014 – 2026 (USD Billion)
5.5.6. HbA1c testing
5.5.6.1. HbA1c testing market, 2014 – 2026 (USD Billion)
5.5.7. Comprehensive metabolic panel testing
5.5.7.1. Comprehensive metabolic panel testing market, 2014 – 2026 (USD Billion)
5.5.8. Liver panel testing
5.5.8.1. Liver panel testing market, 2014 – 2026 (USD Billion)
5.5.8.2. Hepatitis
5.5.8.2.1. Hepatitis market, 2014 – 2026 (USD Billion)
5.5.8.3. Bile duct obstruction
5.5.8.3.1. Bile duct obstruction market, 2014 – 2026 (USD Billion)
5.5.8.4. Liver Cirrhosis
5.5.8.4.1. Liver Cirrhosis market, 2014 – 2026 (USD Billion)
5.5.8.5. Liver Cancer
5.5.8.5.1. Liver Cancer market, 2014 – 2026 (USD Billion)
5.5.8.6. Bone disease
5.5.8.6.1. Bone disease market, 2014 – 2026 (USD Billion)
5.5.8.7. Autoimmune disorders
5.5.8.7.1. Autoimmune disorders market, 2014 – 2026 (USD Billion)
5.5.8.8. Others
5.5.8.8.1. Others market, 2014 – 2026 (USD Billion)
5.5.9. Renal panel testing
5.5.9.1. Renal panel testing market, 2014 – 2026 (USD Billion)
5.5.10. Lipid panel testing
5.5.10.1. Lipid panel testing market, 2014 – 2026 (USD Billion)
Chapter 6. Clinical Laboratory Tests Market: End-use Estimates & Trend Analysis
6.1. Definitions & Scope
6.2. End-use market share analysis, 2018 & 2026
6.3. End-use Dashboard
6.4. Global Clinical Laboratory Tests Market, by End-use, 2013 to 2026
6.5. Market Size & Forecasts and Trend Analyses, 2013 to 2026 for the following,
6.5.1. Central Laboratories
6.5.1.1. Central laboratories market, 2014 – 2026 (USD Billion)
6.5.1.2. Complete blood count
6.5.1.2.1. Complete blood count market, 2014 – 2026 (USD Billion)
6.5.1.3. HGB/HCT testing
6.5.1.3.1. HGB/HCT testing market, 2014 – 2026 (USD Billion)
6.5.1.4. Basic metabolic panel testing
6.5.1.4.1. Basic metabolic panel testing market, 2014 – 2026 (USD Billion)
6.5.1.5. BUN creatinine testing.
6.5.1.5.1. BUN creatinine testing. market, 2014 – 2026 (USD Billion)
6.5.1.6. Electrolytes testing
6.5.1.6.1. Electrolytes testing market, 2014 – 2026 (USD Billion)
6.5.1.7. HbA1c testing
6.5.1.7.1. HbA1c testing market, 2014 – 2026 (USD Billion)
6.5.1.8. Comprehensive metabolic panel testing
6.5.1.8.1. Comprehensive metabolic panel testing market, 2014 – 2026 (USD Billion)
6.5.1.9. Liver panel testing
6.5.1.9.1. Liver panel testing market, 2014 – 2026 (USD Billion)
6.5.1.10. Renal panel testing
6.5.1.10.1. Renal panel testing market, 2014 – 2026 (USD Billion)
6.5.1.11. Lipid panel testing
6.5.1.11.1. Lipid panel testing market, 2014 – 2026 (USD Billion)
6.5.2. Primary Clinics
6.5.2.1. Primary clinics market, 2014 – 2026 (USD Billion)
6.5.2.2. Complete blood count
6.5.2.3. Complete blood count market, 2014 – 2026 (USD Billion)
6.5.2.4. HGB/HCT testing
6.5.2.4.1. HGB/HCT testing market, 2014 – 2026 (USD Billion)
6.5.2.5. Basic metabolic panel testing
6.5.2.5.1. Basic metabolic panel testing market, 2014 – 2026 (USD Billion)
6.5.2.6. BUN creatinine testing
6.5.2.6.1. BUN creatinine testing market, 2014 – 2026 (USD Billion)
6.5.2.7. Electrolytes testing
6.5.2.7.1. Electrolytes testing market, 2014 – 2026 (USD Billion)
6.5.2.8. HbA1c testing
6.5.2.8.1. HbA1c testing market, 2014 – 2026 (USD Billion)
6.5.2.9. Comprehensive metabolic panel testing
6.5.2.9.1. Comprehensive metabolic panel testing market, 2014 – 2026 (USD Billion)
6.5.2.10. Liver panel testing
6.5.2.10.1. Liver panel testing market, 2014 – 2026 (USD Billion)
6.5.2.11. Renal panel testing.
6.5.2.11.1. Renal panel testing. market, 2014 – 2026 (USD Billion)
6.5.2.12. Lipid panel testing
6.5.2.12.1. Lipid panel testing market, 2014 – 2026 (USD Billion)
Chapter 7. Clinical Laboratory Tests Market: Regional Estimates & Trend analysis, by type, end-use and end-use by type
7.1. Regional Market Snapshot
7.2. Regional Market Share and Leading Players, 2018
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.3.1. North America
7.3.2. Europe
7.3.3. Asia Pacific
7.3.4. Latin America
7.3.5. Middle East & Africa
7.4. Market Size, & Forecasts, and Trend Analysis, 2018 to 2026
7.4.1. North America
7.4.1.1. North America clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.1.1.1. U.S.
7.4.1.1.1.1. U.S. clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.1.1.2. Canada
7.4.1.1.2.1. Canada clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.2. Europe
7.4.2.1. Europe clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.2.1.1. U.K.
7.4.2.1.1.1. U.K. clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.2.1.2. Germany
7.4.2.1.2.1. Germany clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.2.1.3. Spain
7.4.2.1.3.1. Spain clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.2.1.4. France
7.4.2.1.4.1. France clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.2.1.5. Italy
7.4.2.1.5.1. Italy clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.2.1.6. Russia
7.4.2.1.6.1. Russia clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.3. Asia Pacific
7.4.3.1. Asia Pacific clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.3.1.1. China
7.4.3.1.1.1. China clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.3.1.2. Japan
7.4.3.1.2.1. Japan clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.3.1.3. India
7.4.3.1.3.1. India clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.3.1.4. South Korea
7.4.3.1.4.1. South Korea clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.3.1.5. Singapore
7.4.3.1.5.1. Singapore clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.3.1.6. Australia
7.4.3.1.6.1. Australia clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.4. Latin America
7.4.4.1. Latin America clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.4.1.1. Brazil
7.4.4.1.1.1. Brazil clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.4.1.2. Mexico
7.4.4.1.2.1. Mexico clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.4.1.3. Argentina
7.4.4.1.3.1. Argentina clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.5. Middle East Africa
7.4.5.1. MEA clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.5.1.1. South Africa
7.4.5.1.1.1. South Africa clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.5.1.2. Saudi Arabia
7.4.5.1.2.1. Saudi Arabia clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.5.1.3. U.A.E.
7.4.5.1.3.1. U.A.E. clinical laboratory tests market, 2014 – 2026 (USD Billions)
Chapter 8. Company Profiles
8.1. Strategic Framework
8.1.1. Abbott
8.1.1.1. Company overview
8.1.1.2. Financial framework
8.1.1.3. Product benchmarking
8.1.1.4. Strategic initiatives
8.1.2. ARUP Laboratories
8.1.2.1. Company overview
8.1.2.2. Financial framework
8.1.2.3. Product benchmarking
8.1.2.4. Strategic initiatives
8.1.3. OPKO Health, Inc.
8.1.3.1. Company overview
8.1.3.2. Financial framework
8.1.3.3. Product benchmarking
8.1.3.4. Strategic initiatives
8.1.4. Bioscientia Institut für Medizinische Diagnostik GmbH
8.1.4.1. Company overview
8.1.4.2. Financial framework
8.1.4.3. Product benchmarking
8.1.4.4. Strategic initiatives
8.1.5. Charles River
8.1.5.1. Company overview
8.1.5.2. Financial framework
8.1.5.3. Product benchmarking
8.1.5.4. Strategic initiatives
8.1.6. NeoGenomics Laboratories, Inc.
8.1.6.1. Company overview
8.1.6.2. Financial framework
8.1.6.3. Product benchmarking
8.1.6.4. Strategic initiatives
8.1.7. Genoptix, Inc.
8.1.7.1. Company overview
8.1.7.2. Financial framework
8.1.7.3. Product benchmarking
8.1.7.4. Strategic initiatives
8.1.8. Healthscope
8.1.8.1. Company overview
8.1.8.2. Financial framework
8.1.8.3. Product benchmarking
8.1.8.4. Strategic initiatives
8.1.9. Labco
8.1.9.1. Company overview
8.1.9.2. Financial framework
8.1.9.3. Product benchmarking
8.1.9.4. Strategic initiatives
8.1.10. Laboratory Corporation of America Holdings (LabCorp)
8.1.10.1. Company overview
8.1.10.2. Financial framework
8.1.10.3. Product benchmarking
8.1.10.4. Strategic initiatives
8.1.11. QIAGEN
8.1.11.1. Company overview
8.1.11.2. Financial framework
8.1.11.3. Product benchmarking
8.1.11.4. Strategic initiatives
8.1.12. Quest Diagnostics
8.1.12.1. Company overview
8.1.12.2. Financial framework
8.1.12.3. Product benchmarking
8.1.12.4. Strategic initiatives
8.1.13. Siemens Healthcare GmbH
8.1.13.1. Company overview
8.1.13.2. Financial framework
8.1.13.3. Product benchmarking
8.1.13.4. Strategic initiatives
8.1.14. Sonic Healthcare
8.1.14.1. Company overview
8.1.14.2. Financial framework
8.1.14.3. Product benchmarking
8.1.14.4. Strategic initiatives
8.1.15. Fresenius Medical Care Holdings, Inc.
8.1.15.1. Company overview
8.1.15.2. Financial framework
8.1.15.3. Product benchmarking
8.1.15.4. Strategic initiatives
8.1.16. Merck KgaA
8.1.16.1. Company overview
8.1.16.2. Financial framework
8.1.16.3. Product benchmarking
8.1.16.4. Strategic initiatives
8.1.17. Tulip Diagnostics (P) Ltd.
8.1.17.1. Company overview
8.1.17.2. Financial framework
8.1.17.3. Product benchmarking
8.1.17.4. Strategic initiatives
8.1.18. Biosino Bio-technology and Science Inc
8.1.18.1. Company overview
8.1.18.2. Financial framework
8.1.18.3. Product benchmarking
8.1.18.4. Strategic initiatives

facebooktwittergoogle_plusredditpinterestlinkedinmail